
FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer
The FDA has granted orphan drug designation to FF-10832—an investigational liposomal formulation of gemcitabine—for the treatment of patients with biliary tract cancer.1 “Biliary tract cancers are rare but aggressive malignancies associated with a poor …